EEG changes in the treatment with octoclothepine in very high doses.
D000293:Adolescent; D000328:Adult; D001582:Benzothiepins / Q000008:administration & dosage* / Q000627:therapeutic use; D001714:Bipolar Disorder / Q000188:drug therapy* / Q000503:physiopathology; D001921:Brain / Q000503:physiopathology*; D002908:Chronic Disease; D003988:Dibenzothiepins / Q000031:analogs & derivatives; D004569:Electroencephalography; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010879:Piperazines / Q000008:administration & dosage / Q000627:therapeutic use; D012559:Schizophrenia / Q000188:drug therapy* / Q000503:physiopathology; D014149:Tranquilizing Agents / Q000008:administration & dosage* / Q000627:therapeutic use
D001582:Benzothiepins; D003988:Dibenzothiepins; D010879:Piperazines; D014149:Tranquilizing Agents